News About: Pharm. Industry
GSK plans to abolish incentive which they give to salesperson in accordance with sales performance
It was known that multinational pharmaceutical company GSK plans to abolish incentive which they give to salesperson in accordance with sales performance, and to introduce new assessment system.
GSK concerns that the...
Hyundai Securities expected domestic market growth rate to be 5% + α, but exports to maintain a high growth trend
Hyundai Securities has recently released a report with an analysis of the pharmaceutical industry, and expected domestic market growth rate to be 5% + α, but exports to maintain a high growth trend.
According to the ...
The entire size of OTC market slightly increased compared to the previous year
According to the data of OTC sales in the past year (from the second, third, and fourth quarter of 2013 to the first quarter of 2014) compiled by IMS, the entire scale of OTC market was turned out to be 1.8639 trillio...
Boryung Pharmaceutical's 'Kanarb' recorded a total of 115.5 billion won sales from its release date
Boryung Pharmaceutical's 'Kanarb' recorded a total of 115.5 billion won sales from its release date of March 1, 2011, to three years after the release of this year.
The profit structure of Kanarb can be divided into ...
Janssen Korea signed a strategic partnership with Pfizer Korea, and took charge of domestic promotion of 'Efexor XR' starting from July
On July 10, Janssen Korea announced that they signed a strategic partnership with Pfizer Korea, and took charge of domestic promotion of 'Efexor XR' starting from July 7.
'Efexor XR' is the first SNRI antidepressant ...
Bayer announced regarding discontinuing supply of 'Kogenate FS' that they can supply the drug constantly to 20 patients
According to the Korea Hemophilia Association, on July 1, Bayer announced regarding discontinuing supply of 'Kogenate FS' that they can supply the drug constantly to 20 patients, and continue supplying Kogenate FS to ...
Novartis Korea and Hanmi Pharmaceutical signed a strategic partnership for the sales of type 2 diabetes treatment 'Galvus' and 'Galvusmet’Novartis Korea and Hanmi Pharmaceutical signed a strategic partnership for the sales of type 2 diabetes treatment 'Galvus (vildagliptin)' and 'Galvusmet (vildagliptin / metformi...
|
Sanofi-Aventis Korea proclaimed a new vision of 'The Future Starts Now' with the 10th anniversary of the Sanofi Diabetes DivisionOn July 9, Sanofi-Aventis Korea announced that they proclaim a new vision of 'The Future Starts Now' with the 10th anniversary of the Sanofi Diabetes Division entering the count...
|
There occur several side effects due to the relation of master and servant in sales partnership between domestic company and multinational company
Recently, mid-sized pharmaceutical company A received notice of the cancellation of a contract from multinational pharmaceutical company B which has been joined hands with company A for thirteen year. The company A su...
Mid-sized pharmaceutical companies as well as large pharmaceutical companies seem to find proper target for undertaking
In recent years, pharmaceutical companies seem to take over companies on the basis of ample funding. Mid-sized pharmaceutical companies as well as large pharmaceutical companies seem to find proper target for undertak...
